A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease

Condition:   Crohn's Disease Intervention:   Drug: Mirikizumab Sponsor:   Eli Lilly and Company Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials